Zeo ScientifiX (ZEOX) Free Cash Flow (2012 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Free Cash Flow of -$202000.0 for Q2 2026, down 41.26% year-over-year from -$343881.0 in Q2 2025, and up 58.35% quarter-over-quarter from -$485000.0 in Q1 2026.
Zeo ScientifiX (ZEOX) Free Cash Flow (2012 - 2026) Analysis & Trends
Zeo ScientifiX's Free Cash Flow history runs 14 years deep, the most recent figure standing at -$202000.0 for Q2 2026.
- In Q2 2026, Free Cash Flow fell 41.26% year-over-year to -$202000.0; the TTM figure through Apr 2026 stood at -$1.3 million (down 146.65% YoY), while the FY2025 annual figure was -$741000.0, up 48.9% from the prior year.
- Free Cash Flow for Q2 2026 stood at -$202000.0, up from -$485000.0 in the prior quarter.
- The five-year high for Free Cash Flow was $215000.0 in Q4 2023, with the low at -$2.1 million in Q4 2022.
- The 5-year median for Free Cash Flow is -$399000.0 (2024), against an average of -$503587.9.
- The sharpest annual moves came in 2025 and 2026: Free Cash Flow soared 111.3% in 2025, then sank 846.15% in 2026.
- Zeo ScientifiX's Free Cash Flow stood at -$2.1 million in 2022, then jumped by 110.41% to $215000.0 in 2023, then tumbled by 270.23% to -$366000.0 in 2024, then retreated by 4.64% to -$383000.0 in 2025, then surged by 47.26% to -$202000.0 in 2026.
- Business Quant data shows ZEOX's Free Cash Flow at -$202000.0 in Q2 2026, -$485000.0 in Q1 2026, and -$383000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | -202,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -202,000.00 |
| Apr 30, 2026 | -202,000.00 |
| Jan 31, 2026 | -485,000.00 |
| Jan 31, 2026 | -485,000.00 |
| Oct 31, 2025 | -383,000.00 |
| Oct 31, 2025 | -383,000.00 |
| Jul 31, 2025 | -257,000.00 |
| Jul 31, 2025 | -257,000.00 |
| Apr 30, 2025 | -143,000.00 |
| Apr 30, 2025 | -143,000.00 |
| Jan 31, 2025 | 65,000.00 |
| Jan 31, 2025 | 65,000.00 |
| Oct 31, 2024 | -366,000.00 |
| Oct 31, 2024 | -366,000.00 |
| Jul 31, 2024 | -94,000.00 |
| Jul 31, 2024 | -94,000.00 |
| Apr 30, 2024 | -415,000.00 |
| Apr 30, 2024 | -415,000.00 |
| Jan 31, 2024 | -575,000.00 |
| Jan 31, 2024 | -575,000.00 |